CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise · Restricted Stock Units | −14,869 | 24,782 | ||
| 2023-05-17 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise · Restricted Stock Units | −14,869 | 24,782 | ||
| 2023-05-01 | Teehan Brendan EVP, COO, Head of Commercial | Grant or award · Stock Options (Right to Buy) | +89,936 | 89,936 | ||
| 2023-05-01 | Teehan Brendan EVP, COO, Head of Commercial | Grant or award · Restricted Stock Units | +27,259 | 27,259 | ||
| 2023-05-01 | DAVIS STEPHEN CEO | Grant or award · Stock Options (Right to Buy) | +295,503 | 295,503 | ||
| 2023-05-01 | DAVIS STEPHEN CEO | Grant or award · Restricted Stock Units | +89,564 | 89,564 | ||
| 2023-05-01 | Schneyer Mark C. EVP, Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +89,936 | 89,936 | ||
| 2023-05-01 | Schneyer Mark C. EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +27,259 | 27,259 | ||
| 2023-05-01 | KIM AUSTIN D. EVP,General Counsel, Secretary | Grant or award · Stock Options (Right to Buy) | +59,957 | 59,957 | ||
| 2023-05-01 | KIM AUSTIN D. EVP,General Counsel, Secretary | Grant or award · Restricted Stock Units | +18,172 | 18,172 | ||
| 2023-05-01 | Kihara James Principal Accounting Officer | Grant or award · Stock Options (Right to Buy) | +17,131 | 17,131 | ||
| 2023-05-01 | Kihara James Principal Accounting Officer | Grant or award · Restricted Stock Units | +10,384 | 10,384 | ||
| 2023-05-01 | KIM AUSTIN D. EVP,General Counsel, Secretary | Sale | −917 | $21.18 | $19K | 25,513 |
| 2023-05-01 | Teehan Brendan EVP, COO, Head of Commercial | Sale | −548 | $21.18 | $12K | 9,487 |
| 2023-05-01 | DAVIS STEPHEN CEO | Sale | −7,806 | $21.18 | $165K | 108,297 |
| 2023-04-29 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise | +3,005 | 26,430 | ||
| 2023-04-29 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise · Restricted Stock Units | −3,005 | 0 | ||
| 2023-04-29 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise | +1,567 | 10,035 | ||
| 2023-04-29 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise · Restricted Stock Units | −1,567 | 0 | ||
| 2023-04-29 | DAVIS STEPHEN CEO | Option exercise | +15,625 | 116,103 |
Page 21 of 63 · 1,260 trades